For the past five years I have been directly involved with EU university laboratories, private research companies, and wholesale suppliers. By 2025 it will be very clear that the choice of formulation has changed from being simply chemistry-based to compliance-survival based.
I have observed regulatory audits, customs inspections, and ethics reviews of companies. In each of these types of reviews the liquid formulation has created issues for the substance whereas the aerosol has been basically problem-free.
This change in formulation has led to a reshaping of the marketplace.
Liquids: Scientifically Flexible, Administratively Fragile
Liquid formulations were the foundation of today's research chemical industry. Liquid formulations are still necessary for:
- The exploration of pharmacology
- The rapid titration of compounds
- Research associated with the synthesis of compounds
In 2025, adaptation and versatility will ensure that the substance will be provided in the manner intended; however, due to the costs of this ability to adapt/versatile, it will also lead to something that all buyers, academic laboratories and private R&D suppliers, and distributors, will face consistently operational deficiencies such as:
- Inconsistent dosing due to pipetting error.
- Degradation due to exposure.
- Poor audit trails through regulatory processes.
During one of the audits I participated in I was a witness to a German audit. While concentration accuracy was something considered, the failure of the liquid was procedural and not scientific.
Why Sprays Are Winning the Compliance Argument
Sprays are not dominating because they are chemically superior. They are dominating because they are behaviorally safer.
From direct observation, sprays result in fewer real-world handling errors than liquids. This matters far more than most researchers admit. Human factors-fatigue, routine shortcuts, inconsistent technique-are now explicitly considered by regulators and ethics boards.
Sprays reduce:
- Open-container exposure
- Operator-dependent variability
- Cross-contamination risk
In Dutch labs especially, sprays have become the preferred format for:
- Observational studies
- Microdosing research
- Multi-operator environments
One procurement manager summarized it perfectly:
“A spray doesn’t trust the technician to be perfect. It assumes they’re human.”
Market Reality: This Is Not a Zero-Sum Shift
Liquids are not disappearing. They remain essential where flexibility is non-negotiable.
But sprays are becoming the default defensible format-the one that raises the fewest red flags when:
- Crossing borders
- Facing internal compliance reviews
- Justifying protocols to ethics boards
Importantly, sprays are not just transitional. Based on 2025 ordering behavior, they are solidifying as a long-term standard for regulated, repeatable research.
The 2025 Verdict
- Liquids dominate innovation
- Sprays dominate justification
- The market rewards whoever can explain their choice clearly
By the end of 2025, the question labs will be asked isn’t “Why did you choose sprays?”
It will be “Why didn’t you?”
And in today’s EU research environment, that difference determines not just sales-but continuity.